Evidence map›Paper›PMID 26159676›Full record

ArticleJournal of neurotrauma2016

Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury.

Frederick K Korley, Ramon Diaz-Arrastia, Alan H B Wu, John K Yue, Geoffrey T Manley, Haris I Sair, Jennifer Van Eyk, Allen D Everett, TRACK-TBI investigators, David O Okonkwo and 8 more

Registry-linked trialOpen access · greenAbstract readMulticenter StudyValidation Study
In one paragraph

Article in Journal of neurotrauma, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04071743 (A Randomized, Single-Center, Double-Blind, Parallel, Sham-Controlled Study of Gammacore Sapphire), which is not on this map. Cited by 85 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 3 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04071743 nawithdrawnnot on this mapstarted 2020, after this paper: background citation

A Randomized, Single-Center, Double-Blind, Parallel, Sham-Controlled Study of Gammacore Sapphire (Non-Invasive Vagus Nerve Stimulator) for the Acute and Preventive Treatment of Post-Traumatic Headache (GAP-PTH)

TypeinterventionalSponsorUniversity of Texas Southwestern Medical CenterRan2020 to 2021Enrolled0ConditionsPost-Traumatic HeadacheArmsgammaCore Sapphire, sham gammaCore Sapphire
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 3 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. BDNF: New Views of an Old Player in Traumatic Brain Injury.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Potential Neuroprotective Role of Neurotrophin in Traumatic Brain Injury.CNS & neurological disorders drug targets · 2024
    Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Frederick K Korley1 Department of Emergency Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland.
Ramon Diaz-Arrastia2 Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences , Bethesda, Maryland.
Alan H B Wu3 Clinical Chemistry Laboratory, San Francisco General Hospital , San Francisco, California.
John K Yue4 Department of Neurological Surgery, University of California San Francisco , San Francisco, California.
Geoffrey T Manley4 Department of Neurological Surgery, University of California San Francisco , San Francisco, California.
Haris I Sair5 Department of Radiology, Johns Hopkins University School of Medicine , Baltimore, Maryland.
Jennifer Van Eyk6 Department of Medicine, the Advanced Clinical Biosystems Research Institute , Cedars Sinai Medical Center, Los Angeles, California.
Allen D Everett7 Department of Pediatrics, Johns Hopkins University School of Medicine , Baltimore, Maryland.
TRACK-TBI investigators
David O Okonkwo8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
Alex B Valadka8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
Wayne A Gordon8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
Andrew I R Maas8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
Pratik Mukherjee8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
Esther L Yuh8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
Hester F Lingsma8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
Ava M Puccio8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
David M Schnyer8 The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Investigators .
LRS Institute of Tuberculosis and Respiratory Diseases · INUniversity of California, San Francisco · USJohns Hopkins University · USCedars-Sinai Medical Center · USErasmus MC · NLSan Francisco General Hospital · USUniformed Services University of the Health Sciences · US

Funding

Transforming Research and Clinical Knowledge in Traumatic Brain InjuryU01NS086090 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DIAZ-ARRASTIA, RAMON, GIACINO, JOSEPH THOMAS · 2013 to 2017
$19.1M
Transforming Traumatic Brain Injury Research and Clinical CareRC2NS069409 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MANLEY, GEOFFREY T · 2009 to 2011
$4.3M
NINDS NIH HHS RC2NS069409NINDS NIH HHS U01NS086090PHS HHS HHSN268201000032C
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) is important for neuronal survival and regeneration. We investigated the diagnostic and prognostic values of serum BDNF in traumatic brain injury (TBI). We examined serum BDNF in two independent cohorts of TBI cases presenting to the emergency departments (EDs) of the Johns Hopkins Hospital (JHH; n = 76) and San Francisco General Hospital (SFGH, n = 80), and a control group of JHH ED patients without TBI (n = 150). Findings were subsequently validated in the prospective, multi-center Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Pilot study (n = 159). We investigated the association between BDNF, glial fibrillary acidic protein (GFAP), and ubiquitin C-terminal hydrolase-L1 (UCH-L1) and recovery from TBI at 6 months in the TRACK-TBI Pilot cohort. Incomplete recovery was defined as having either post-concussive syndrome or a Glasgow Outcome Scale Extended score <8 at 6 months. Median day-of-injury BDNF concentrations (ng/mL) were lower among TBI cases (JHH TBI, 17.5 and SFGH TBI, 13.8) than in JHH controls (60.3; p = 0.0001). Among TRACK-TBI Pilot subjects, median BDNF concentrations (ng/mL) were higher in mild (8.3) than in moderate (4.3) or severe TBI (4.0; p = 0.004. In the TRACK-TBI cohort, the 75 (71.4%) subjects with very low BDNF values (i.e., <the 1st percentile for non-TBI controls, <14.2 ng/mL) had higher odds of incomplete recovery than those who did not have very low values (odds ratio, 4.0; 95% confidence interval [CI]: 1.5-11.0). The area under the receiver operator curve for discriminating complete and incomplete recovery was 0.65 (95% CI: 0.52-0.78) for BDNF, 0.61 (95% CI: 0.49-0.73) for GFAP, and 0.55 (95% CI: 0.43-0.66) for UCH-L1. The addition of GFAP/UCH-L1 to BDNF did not improve outcome prediction significantly. Day-of-injury serum BDNF is associated with TBI diagnosis and also provides 6-month prognostic information regarding recovery from TBI. Thus, day-of-injury BDNF values may aid in TBI risk stratification.

Indexed as

Outcome Assessment, Health CareSeverity of Illness IndexAdultBrain-Derived Neurotrophic FactorBrain InjuriesCase-Control StudiesFemaleHumansMaleMiddle AgedPilot ProjectsProspective StudiesRandom AllocationRecovery of FunctionBDNF protein, humanBrain-Derived Neurotrophic Factorbiomarkersbrain-derived neurotrophic factorglial fibrillary acidic proteintraumatic brain injuryubiquitin C-terminal hydrolase-L1

Identifiers

PMID26159676
PMCPMC4722554
OpenAlexW1911548173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.